Pregenerate

Curated by Signal

Developer of scaleable organ-on-a-chip models for animal testing

Overview

Pregenerate is a developer of scaleable organ-on-a-chip models that can be used instead of animal models for treating arthritis. The company is developing the instrument for testing the therapies for treating degenerative arthritis in humans, sport horses, and our beloved companion animals. Some of the partners are RebelBio, MIIR, SOSV, Vienna University of Technology and Vetmeduni Vienna.

Key facts

Founded: 2019
Headquarters: London, United Kingdom
Stage: Sign up to view
Industry: Health Technology

Contact

Primary office: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Message Dynamics
Provider of a platform for teleconsultation with healthcare professionals
Health TechnologyChertsey, United Kingdom
VETbytes
Mobile application providing research updates and resources to vets
Health TechnologyBrighton, United Kingdom
Diagnost
Provider of mobile app for symptoms checking of multiple diseases
Health TechnologyLondon, United Kingdom

About Pregenerate

What does Pregenerate do?

Pregenerate is a developer of scaleable organ-on-a-chip models that can be used instead of animal models for treating arthritis.

Where is Pregenerate headquartered?

Pregenerate is headquartered in London, United Kingdom.

When was Pregenerate founded?

Pregenerate was founded in 2019.

Which sector is Pregenerate in?

Pregenerate operates in Health Technology.

Who are Pregenerate's competitors?

Companies similar to Pregenerate include Message Dynamics, VETbytes, and Diagnost.